08.05.2013

The EMA's plan on access to raw data - transparency or commerce?

Burkhard Sträter warns that making raw data from clinical trials publically available breaches data protection law. Drug regulators in the EU can learn an important lesson on data protection from... Scrip Regulatory Affairs